期刊文献+

mRNA差异显示法在分离肿瘤转移相关基因中的初步应用 被引量:2

Preliminary Application of mRNA Differential Display Technique in the Isolation of Genes Possibly Associated with Tumor Metastasis
暂未订购
导出
摘要 用mRNA差异显示技术(mRNAdifferentialdisplay)对分别用200U/ml重组人IFN-a和IFN-Υ处理的MA891肿瘤细胞系总mRNA进行分析,分离出10个差异表达的片段,并进行了克隆。因IFN-a抑制MA891细胞系的肺转移能力,而IFN-Υ则增强其肺转移能力,故认为该10个片段所代表的基因中可能有某个或几个基因与肿瘤转移有关。 We have previously reported that in vitro treatment with interferons of MA891, a spon-taneous mouse mammary tumor capable of metastasizing to the lungs upon subcutaneous in-oculation, could modulate its metastatic potential- IFN-Y increases while IFN-a decreaseslung metastasis. Identifying the genes differentially expressed in MA891 cells separatelytreated with IFN-a and IFN-Y. MA891 cells were treated in vitro with 2ooU/ml IFN-a orIFN-Y respectively for 48h. Total RNA was isolated with the single step method of acidguanidinium thiocyanate. After being digested by DNase I, the two RNA samples were dif-ferentially displayed with Tl2MA/T/C/G X 20 arbitrary primer pairs. Most of the RT-PCRwere done twice. The differentially expressed cDNA bands were isolated, reampliated andcloned. Ten differentially expressed cDNA bands were identified: T2a,T2Y,C4a,T6a,T1lY,G15Y,T16Y, T5a1, T5a2,T17a, T15a, T15Y, named according to the type of IFN and primerpairs used. The total RNA samples of MA891 cells treated by IFN-a and IFN-Y were differ-entially displayed with T12MA/T/C/G X 20 arbitrary primer pairs. Theoretically they cancover 95 % mRNAs- It is anticipated that one or more of the ten cDNA clones may be relatedto the metastatic potential of MA891 cells.
出处 《中国医学科学院学报》 CAS CSCD 北大核心 1997年第5期384-388,共5页 Acta Academiae Medicinae Sinicae
关键词 MRNA 差异显示 肿瘤转移 干扰素 mRNA differential display metastasis interferon
  • 相关文献

参考文献2

  • 1罗利群,中华肿瘤杂志,1994年,16卷,251页
  • 2Liang P,Science,1992年,257卷,967页

同被引文献19

  • 1罗利群,张友会.γ-干扰素促进小鼠乳腺癌的转移[J].中华肿瘤杂志,1994,16(4):251-254. 被引量:7
  • 2王莉,陆玮.mRNA差异显示技术与肿瘤分子生物学研究[J].国外医学(肿瘤学分册),1996,23(2):84-86. 被引量:3
  • 3罗利群 张友会 等.干扰素对小鼠乳腺癌细胞侵袭力及对侵袭转移相关基因表达的调变[J].中华肿瘤杂志,1997,19:184-187.
  • 4侯云德.分子克隆实验指南,第2版[M].北京:科学出版社,1992..
  • 5Oltvai Z N, Milliman C L, Korsmeyer S T, et al. Bcl-2 heterolimerizes in vivo with a conserved homologous bax, that accelerater programmed cell death. Cell, 1993, 74:609 -619.
  • 6Krejewski S, Krejewska M, Shabaik A, et al.Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. Am J Pathol, 1994, 145(6) :1323 - 1336.
  • 7Bargou R C, Daniel P T, Mapara M T, et al. Expression of the bcl-2 gene family in normal and malignant breast tissue: low bax-alpha expression in tumor cells correlates with resistance towards apoptosis. Int J Cancer,1995,60(6) :854 - 859.
  • 8Harnois D M, Que F G, Celli A, et al. Bcl-2 is overexpressed and alters the threshold for apoptosis in a cholangiocarcinoma cell line. Hepatology, 1997,26:885 - 890.
  • 9Sager R. Tumor suppressor genes: the puzzle and the promise,Science, 1989,246(4936 ) : 1406 - 1412.
  • 10Aronson S A. Growth factors and cancer. Science, 1991,254(5035) :1146 - 1153.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部